NeurAxis Announces Capital Blue Cross Medical Policy Coverage for PENFS, effective October 1st 2024

Oct 29, 2024 | Press Releases

CARMEL, Ind., Oct. 29, 2024 (GLOBE NEWSWIRE) — NeurAxis, Inc. (“NeurAxis,” or the “Company”) (NYSE American: NRXS), a medical technology company commercializing neuromodulation therapies addressing chronic and debilitating conditions in...

NeurAxis Announces New CPT® Category I Code for Percutaneous Electrical Nerve Field Stimulation

Oct 22, 2024 | Press Releases

CARMEL, Ind., Oct. 22, 2024 (GLOBE NEWSWIRE) — NeurAxis, Inc. (“NeurAxis,” or the “Company”) (NYSE American: NRXS), a medical technology company commercializing neuromodulation therapies addressing chronic and debilitating conditions in...

NeurAxis to Participate in the Lytham Partners Fall 2024 Investor Conference on October 1, 2024

Sep 19, 2024 | Press Releases

CARMEL, Ind., Sept. 19, 2024 (GLOBE NEWSWIRE) — NeurAxis, Inc. (“NeurAxis,” or the “Company”) (NYSE American: NRXS), a medical technology company commercializing neuromodulation therapies addressing chronic and debilitating conditions in...

NeurAxis Announces Geisinger Health Plan Medical Policy Coverage for PENFS, Effective September 15 2024

Aug 27, 2024 | Press Releases

CARMEL, Ind., Aug. 27, 2024 (GLOBE NEWSWIRE) — NeurAxis, Inc. (“NeurAxis,” or the “Company”) (NYSE American: NRXS), a medical technology company commercializing neuromodulation therapies addressing chronic and debilitating conditions in...

NeurAxis Announces BCBS of Vermont Medical Policy Coverage for PENFS, effective October 1st 2024

Aug 13, 2024 | Press Releases

CARMEL, Ind., Aug. 13, 2024 (GLOBE NEWSWIRE) — NeurAxis, Inc. (“NeurAxis,” or the “Company”) (NYSE American: NRXS), a medical technology company commercializing neuromodulation therapies addressing chronic and debilitating conditions in...

NeurAxis Reports Second Quarter 2024 Financial Results

Aug 9, 2024 | Press Releases

Conference call will be held today, Friday, August 9 at 9:00 am ETCarmel, Ind., Aug. 09, 2024 (GLOBE NEWSWIRE) — NeurAxis, Inc. (“NeurAxis,” or the “Company”) (NYSE American: NRXS), a medical technology company commercializing...